Cite

HARVARD Citation

    Kong, F. et al. (2021). Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single‐arm, open‐label, phase 3 trial. Journal of gastroenterology and hepatology. 36 (9), pp. 2375-2382. [Online]. 
  
Back to record